Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

omipalisib MeSH Supplementary Concept Data 2025


MeSH Supplementary
omipalisib
Unique ID
C561454
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C561454
Entry Term(s)
2,4-difluoro-N-(2-(methyloxy)-5-(4-(4-pyridazinyl)-6-quinolinyl)-3-pyridinyl)benzenesulfonamide
GSK 212
GSK 2126458
GSK-212
GSK-2126458
GSK212
GSK2126458
Registry Numbers
1X8F5A3NA0
0
Heading Mapped to
*Pyridazines
*Quinolines
*Benzenesulfonamides
Frequency
28
Note
inhibitor of mTOR protein
Source
Cancer Biol Ther 2011 Jun 1;11(11):938-46
Date of Entry
2011/09/30
Revision Date
2023/06/22
omipalisib Preferred
GSK 2126458 Narrower
GSK 212 Narrower
page delivered in 0.004s